Showing results (271-280 of 320) with videos related to
Sort By:
Pageof 32
Modern Rheumatology|August 25, 2023
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' studyMasayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.Journal of Radiation Research|January 24, 2015
Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rateNaoyuki Kanayama, Fumiaki Isohashi, Yasuo Yoshioka, et al.Plos One|November 16, 2022
Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world dataEiichi Tanaka, Eisuke Inoue, Ayako Shoji, et al.International Journal of Oncology|December 7, 2016
Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, western blotting and mRNA quantificationTakehiro Maki, Hiroaki Ikeda, Aki Kuroda, et al.Brachytherapy|September 12, 2016
Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancerSungjae Baek, Fumiaki Isohashi, Hiroko Yamaguchi, et al.Annals of the Rheumatic Diseases|January 7, 2016
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka, et al.Modern Rheumatology|December 17, 2021
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare DatabaseKenji Nagasaka, Shinya Kaname, Koichi Amano, et al.Brachytherapy|November 28, 2015
Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?Ken Yoshida, Hideya Yamazaki, Tadayuki Kotsuma, et al.Journal of Contemporary Brachytherapy|January 24, 2020
A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancerKen Yoshida, Tadayuki Kotsuma, Hironori Akiyama, et al.International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Nationwide, Multicenter, Retrospective Study on High-Dose-Rate Brachytherapy as Monotherapy for Prostate CancerYasuo Yoshioka, Tadayuki Kotsuma, Akira Komiya, et al.Pageof 32